Vimarsana
Biggest News Aggregation in the World

Page 13 - Vascular Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vascular Access Today - Breaking & Trending Today

Henry Ford Health nephrologist-led study evaluates and validates vascular monitoring technology - Vimarsana News

Henry Ford Health nephrologist-led study evaluates and validates vascular monitoring technology

Research led by Henry Ford Health's Lalathaksha Kumbar, M.D., evaluated and validated a remote access monitoring technology that can predict vascular access blockages in dialysis patients.

Tenapanor Nears US Approval for Hyperphosphatemia in Dialysis - Vimarsana News

Tenapanor Nears US Approval for Hyperphosphatemia in Dialysis

The FDA granted an appeal to an earlier decision, resetting tenapanor on a path toward approval for treating hyperphosphatemia in patients undergoing dialysis.

Post-AKI Care in a Dedicated Follow-up Clinic May Up Survival - Vimarsana News

Post-AKI Care in a Dedicated Follow-up Clinic May Up Survival

A single-center study shows lower mortality and fewer cardiovascular events in patients seen in a follow-up clinic after discharge for acute kidney injury, stressing the "importance of post-AKI care."

Symptoms Worsen Before Dialysis, Ease After, in Older Patients With CKD - Vimarsana News

Symptoms Worsen Before Dialysis, Ease After, in Older Patients With CKD

'We hope these results could help inform older patients with kidney failure who decide to start dialysis on what to expect regarding the development of their symptom burden,' say researchers.

EHR Alerts Flag Acute Kidney Injury and Avert Progression - Vimarsana News

EHR Alerts Flag Acute Kidney Injury and Avert Progression

Automated EHR alerts for hospitalized patients alerted clinicians when acute kidney injury developed, triggered stoppage of potentially exacerbating medications, and sometimes improved clinical outcomes.